Secreted RVG- exosome-delivered siRNA down-regulates opioid ... that MOR is down-regulated by IV injection of MV-RNAi in vivo. The down-regulation of MOR significantly abolishes morphine relapse.

Figure 3: In vivo delivery of siRNA with targeted exosomes results in brain-specific gene knockdown. To further investigate the brain targeting of RVG exosomes, transverse cortical sections from ...

OXFORD, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced two oral presentations at the ...

Dec. 02, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new ...

In addition, efficient methods for delivering siRNAs to bacteria in vivo are not currently available. In this study, the authors demonstrated that exosomes can serve as delivery vehicles to ...

To study exosomes in vivo, the team introduced pancreatic cancer cells into the peritoneal cavity of mice. One month later, they used immunohistochemistry to measure LAT1 expression in tumor tissue ...

The RVG-exosome-delivered RNAi against opioid receptor ... that MOR is down-regulated by IV injection of MV-RNAi in vivo. The down-regulation of MOR significantly abolishes morphine relapse.

The RVG-exosome-delivered RNAi against opioid receptor ... that MOR is down-regulated by IV injection of MV-RNAi in vivo. The down-regulation of MOR significantly abolishes morphine relapse.

The RVG-exosome-delivered RNAi against opioid receptor ... that MOR is down-regulated by IV injection of MV-RNAi in vivo. The down-regulation of MOR significantly abolishes morphine relapse.